{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:19:19Z","timestamp":1782904759945,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.nmd.2025.105336","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:12:03Z","timestamp":1740827523000},"page":"105336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fluoroscopic guidance for intrathecal delivery of nusinersen in pediatric patients with spinal muscular atrophy and complex spines"],"prefix":"10.1016","volume":"49","author":[{"given":"Shany","family":"Lando - Dotan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliyahu","family":"Perlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Shkalim Zemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elchanan","family":"Bruckheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Tzeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzipora","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-6276","authenticated-orcid":false,"given":"Sharon","family":"Aharoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105336_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2023.151326","article-title":"Challenges and future perspective of antisense therapy for spinal muscular atrophy: a review","volume":"102","author":"Nakevska","year":"2023","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.nmd.2025.105336_bib0002","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.3390\/ijms241914873","article-title":"Spinal muscular atrophy: an evolving scenario through new perspectives in diagnosis and advances in therapies","volume":"24","author":"Angilletta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105336_bib0003","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.pcl.2023.06.002","article-title":"Spinal muscular atrophy: a (now) treatable neurodegenerative disease","volume":"70","author":"Fay","year":"2023","journal-title":"Pediatr Clin N Am"},{"key":"10.1016\/j.nmd.2025.105336_bib0004","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.nmd.2019.08.007","article-title":"Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: transforaminal versus conventional approach","volume":"29","author":"Bortolani","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105336_bib0005","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/brainsci13101419","article-title":"Safety and efficacy of nusinersen and risdiplam for spinal muscular atrophy: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Qiao","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.nmd.2025.105336_bib0006","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s12325-022-02376-y","article-title":"Adherence and persistence to nusinersen for spinal muscular atrophy: a US claims-based analysis","volume":"40","author":"Fox","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.nmd.2025.105336_bib0007","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","article-title":"Advances and limitations for the treatment of spinal muscular atrophy","volume":"22","author":"Day","year":"2022","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.nmd.2025.105336_bib0008","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.3390\/ijms241511939","article-title":"Spinal muscular atrophy: the past, present, and future of diagnosis and treatment","volume":"24","author":"Nishio","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105336_bib0009","unstructured":"Food and Drug Administration. SPINRAZA (Nusinersen) injection, for intrathecal use. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/209531lbl.pdf. [accessed on 9 November 2023]."},{"key":"10.1016\/j.nmd.2025.105336_bib0010","doi-asserted-by":"crossref","DOI":"10.23736\/S2724-5276.23.07198-7","article-title":"Posterior spinal fusion in patients with spinal muscular atrophy: a surgical technique to allow intrathecally inject nusinersen","author":"Amico","year":"2023","journal-title":"Minerva Pediatr (Torino)"},{"issue":"15 Suppl","key":"10.1016\/j.nmd.2025.105336_bib0011","first-page":"464","article-title":"Use of Ommaya reservoir with a thoracic spinal catheter for intrathecal delivery of nusinersen in a patient with spinal muscular atrophy type 2","volume":"90","author":"Lakhotia","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105336_bib0012","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1212\/WNL.0000000000006006","article-title":"Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy","volume":"91","author":"Veerapandiyan","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105336_bib0013","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00247-017-4031-6","article-title":"Transforaminal intrathecal delivery of nusinersen using cone-beam computed tomography for children with spinal muscular atrophy and extensive surgical instrumentation: early results of technical success and safety","volume":"48","author":"Weaver","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.nmd.2025.105336_bib0014","first-page":"e36197","article-title":"Gene therapy for spinal muscular atrophy (SMA): a review of current challenges and safety considerations for Onasemnogene Abeparvovec (Zolgensma)","volume":"15","author":"Ogbonmide","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.nmd.2025.105336_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3174\/ajnr.A6351","article-title":"Simple fluoroscopy-guided transforaminal lumbar puncture: safety and effectiveness of a coaxial curved-needle technique in patients with spinal muscular atrophy and complex spines","volume":"41","author":"Jacobson","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.nmd.2025.105336_bib0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/neurintsurg-2020-016058","article-title":"Transforaminal intrathecal delivery of nusinersen for older children and adults with spinal muscular atrophy and complex spinal anatomy: an analysis of 200 consecutive injections","volume":"13","author":"Weaver","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.nmd.2025.105336_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0004-282x-anp-2020-0200","article-title":"Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery","volume":"79","author":"Mendon\u00e7a","year":"2021","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nmd.2025.105336_bib0018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.26899","article-title":"Intrathecal delivery of nusinersen in individuals with complicated spines","volume":"62","author":"Cartwright","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105336_bib0019","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/rapm-2021-103242","article-title":"Transforaminal lumbar puncture for spinal anesthesia or novel drug administration: a technique combining C-arm fluoroscopy and ultrasound","volume":"47","author":"Berde","year":"2022","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.nmd.2025.105336_bib0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/ene.14586","article-title":"Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients","volume":"28","author":"Veiga-Canuto","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.105336_bib0021","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00247-021-05126-4","article-title":"Intrathecal catheter and port placement for nusinersen infusion in children with spinal muscular atrophy and spinal fusion","volume":"51","author":"Shashi","year":"2021","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.nmd.2025.105336_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2022.04.008","article-title":"Nusinersen for patients with spinal muscular atrophy: 1415 doses via an interdisciplinary institutional approach","volume":"132","author":"Madan","year":"2022","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105336_bib0023","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5152\/dir.2020.19607","article-title":"Nusinersen injections in adults and children with spinal muscular atrophy: a single-center experience","volume":"26","author":"\u00d6z\u00fctemiz","year":"2020","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.nmd.2025.105336_bib0024","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3174\/ajnr.A5596","article-title":"Transforaminal lumbar puncture: an alternative technique in patients with challenging access","volume":"39","author":"Nascene","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.nmd.2025.105336_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tnsci-2017-0001","article-title":"ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy","volume":"8","author":"Ottesen","year":"2017","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.nmd.2025.105336_bib0026","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mus.27187","article-title":"Safety and efficacy of nusinersen in spinal muscular atrophy: the EMBRACE study","volume":"63","author":"Acsadi","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105336_bib0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2474-14-283","article-title":"Natural course of scoliosis in proximal spinal muscular atrophy type II and IIIa: descriptive clinical study with retrospective data collection of 126 patients","volume":"14","author":"Fujak","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.nmd.2025.105336_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.006765","article-title":"Projected future cancer risks in children treated with fluoroscopy-guided cardiac catheterization procedures","volume":"11","author":"Journy","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.nmd.2025.105336_bib0029","first-page":"711","article-title":"Quantifying cancer risk from exposures to medical imaging in the Risk of pediatric and adolescent Cancer associated with Medical Imaging (RIC) Study: research methods and cohort profile","volume":"33","author":"Kwan","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.nmd.2025.105336_bib0030","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/s41591-023-02620-0","article-title":"Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults","volume":"29","author":"Bosch de","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2025.105336_bib0031","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ije\/29.3.424","article-title":"Cancer following cardiac catheterization in childhood","volume":"29","author":"Modan","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.nmd.2025.105336_bib0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/tomography10030025","article-title":"Evaluation of radiation exposure and influential factors in cone-beam computed tomography (CBCT) of the head and abdomen during interventional procedures","volume":"10","author":"Li","year":"2024","journal-title":"Tomography"},{"key":"10.1016\/j.nmd.2025.105336_bib0033","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mus.27518","article-title":"Ultrasound-guided transforaminal approach for nusinersen delivery in adult spinal muscle atrophy patients with challenging access","volume":"65","author":"Snoj","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105336_bib0034","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00415-023-11560-1","article-title":"SUNFISH Working Group. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA)","volume":"270","author":"Oskoui","year":"2023","journal-title":"J Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662500063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:07:40Z","timestamp":1762344460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662500063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"alternative-id":["S096089662500063X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105336","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroscopic guidance for intrathecal delivery of nusinersen in pediatric patients with spinal muscular atrophy and complex spines","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105336"}}